scholarly journals Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

2011 ◽  
Vol 13 (3) ◽  
pp. R94 ◽  
Author(s):  
Suzanne Arends ◽  
Elisabeth Brouwer ◽  
Eveline van der Veer ◽  
Henk Groen ◽  
Martha K Leijsma ◽  
...  
Keyword(s):  
Cohort Study ◽  
Tumor Necrosis ◽  
Observational Cohort Study ◽  
Necrosis Factor Alpha ◽  
Alpha Blocking ◽  
Predictors Of Response ◽  
Observational Cohort ◽  
Factor Alpha ◽  
Prospective Longitudinal ◽  
Necrosis Factor

scholarly journals Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report

2013 ◽  
Vol 88 (6 suppl 1) ◽  
pp. 26-28 ◽  
Author(s):  
Guida Santos ◽  
Lourdes Emerenciano Sousa ◽  
Alexandre Miguel Bruno Lopes João
Keyword(s):  
Tumor Necrosis ◽  
Tnf Alpha ◽  
Paradoxical Effect ◽  
Cutaneous Sarcoidosis ◽  
Cutaneous Lesions ◽  
Current Case ◽  
Necrosis Factor Alpha ◽  
Alpha Blocking ◽  
Factor Alpha ◽  
Necrosis Factor

The paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been described frequently as a result of the widespread use of these drugs. Among the TNF-alpha blocking agents, few reports exist relating the use of adalimumab in cutaneous sarcoidosis, although all of them show good results. More recently, sarcoidosis onsets have been reported with various TNF-alpha inhibitors. The current case is, to our knowledge, the first to describe the exacerbation of cutaneous lesions of sarcoidosis treated with adalimumab.

Sign in / Sign up

Export Citation Format

Share Document